Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants
- 31 July 1992
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (5) , 915-921
- https://doi.org/10.1016/0192-0561(92)90091-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- T-cell subsets, IFN-γ production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cellsInternational Journal of Cancer, 1990
- Resistance to murine cutaneous leishmaniasis is mediated by TH1 cells, but disease-promoting CD4+ cells are different from TH2 cellsEuropean Journal of Immunology, 1990
- Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: Relationship to MuLV gp70European Journal of Immunology, 1990
- Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cellsInternational Journal of Immunopharmacology, 1990
- Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagensCancer Immunology, Immunotherapy, 1989
- Heterogeneity of Cytokine Secretion Patterns and Functions of Helper T CellsPublished by Elsevier ,1989
- Induction of tumor suppression and delayed‐type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variantInternational Journal of Cancer, 1988
- Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variantInternational Journal of Cancer, 1987
- Chemical xenogenization of experimental tumorsCancer and Metastasis Reviews, 1987
- Antigenic Tumor Cell Variants Obtained with MutagensAdvances in Cancer Research, 1983